iGan Partners
iGan Partners is a Toronto-based, healthcare-focused venture capital firm that provides early-stage capital and operational support to companies commercializing AI-enabled MedTech and digital health technologies. The firm invests at Seed through Series A and provides follow-on funding through to exit, offering smart capital, active support, mentorship, and access to industry and co-investor networks to help portfolio companies scale globally.
iGan Partners
Services
Equity Investment (Seed to Series A) and Follow-on Funding
Provides direct capital by investing at Seed and Series A stages and offers follow-on funding through to exit.
Active Board/Deal Support and Strategic Guidance
Provides deal structuring, board participation, domain expertise and hands-on operational support from a team of entrepreneurs, operators and investors.
Network Access and Sector-Specific Co-Investors
Connects portfolio companies to industry partners, sector-specific co-investors and distribution or commercialization partners.
Talent and Company Building Support
Provides access to experienced operators, recruiting support and management experience to help scale startups into longer-term companies.
Founding / Program Support and Event Sponsorship
Sponsors industry events and competitions (e.g., Pitch to Heal, Health Innovation Week) and supports promotional and ecosystem activities to surface and evaluate deal flow.
Equity Investment (Seed to Series A) and Follow-on Funding
Provides direct capital by investing at Seed and Series A stages and offers follow-on funding through to exit.
Active Board/Deal Support and Strategic Guidance
Provides deal structuring, board participation, domain expertise and hands-on operational support from a team of entrepreneurs, operators and investors.
Network Access and Sector-Specific Co-Investors
Connects portfolio companies to industry partners, sector-specific co-investors and distribution or commercialization partners.
Talent and Company Building Support
Provides access to experienced operators, recruiting support and management experience to help scale startups into longer-term companies.
Founding / Program Support and Event Sponsorship
Sponsors industry events and competitions (e.g., Pitch to Heal, Health Innovation Week) and supports promotional and ecosystem activities to surface and evaluate deal flow.
Portfolio
Provider of high-resolution micro-ultrasound systems (ExactVu); cited in multiple portfolio announcements and press items.
#Medical imaging / MedTech
Developer of the MolecuLight i:X fluorescence wound imaging device; multiple clinical and commercial milestones and financing events reported on the firm site.
#Medical device (wound imaging)
Developer of electronic glasses for low vision; referenced with partnerships, product launches and awards in site posts.
#Assistive vision devices / MedTech
Provider of IoT wearable ultrasound-based monitoring devices; referenced in fundraising and board expansion posts.
#Medical devices (non-invasive hemodynamic monitoring)
iGan led the Seed+ financing to support U.S. expansion, clinical validation and commercial growth (June 5, 2025 announcement).
#Personalized gynecological devices / MedTech
Investment announced May 29, 2025; company develops confidential AI infrastructure for regulated industries.
#Confidential AI infrastructure
Provider of high-resolution micro-ultrasound systems (ExactVu); cited in multiple portfolio announcements and press items.
#Medical imaging / MedTech
Developer of the MolecuLight i:X fluorescence wound imaging device; multiple clinical and commercial milestones and financing events reported on the firm site.
#Medical device (wound imaging)
Developer of electronic glasses for low vision; referenced with partnerships, product launches and awards in site posts.
#Assistive vision devices / MedTech
Provider of IoT wearable ultrasound-based monitoring devices; referenced in fundraising and board expansion posts.
#Medical devices (non-invasive hemodynamic monitoring)
iGan led the Seed+ financing to support U.S. expansion, clinical validation and commercial growth (June 5, 2025 announcement).
#Personalized gynecological devices / MedTech
Investment announced May 29, 2025; company develops confidential AI infrastructure for regulated industries.
#Confidential AI infrastructure